Search Results 511-520 of 20936 for Crohns disease

  1. Gastroenterology - Mayo Clinic News Network

    ... and treating some of the world's most serious and complex diseases. ... Mayo patient cycles 4,500 miles after ostomy surgery for Crohn's disease featured image.

  2. Ulcerative colitis - Doctors and departments - Mayo Clinic

    This type of inflammatory bowel disease causes swelling and sores in the digestive tract. Learn more about symptoms and treatment.

  3. A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Moderate-to-Severe, Active Crohn's Disease - Mayo Clinic

    Clinical Trials · A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Moderate-to-Severe, Active Crohn's Disease.

  4. Jonathan A. Leighton, M.D. - Mayo Clinic Faculty Profiles

    He has a particular interest in inflammatory bowel disease, colorectal neoplasia and diseases of the small bowel, including obscure gastrointestinal bleeding.

  5. Adalimumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab injection is also used to treat the symptoms of active Crohn's disease in adults and children 6 years of age and older who have not been helped by ...

  6. A Study to Evaluate Posaconazole to Treat Genetically-defined Patients with Active Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. ... AND active symptoms of Crohn's disease ( ...

  7. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

    Is male or female with Ulcerative Colitis or Crohn's Disease and was between 2 to 17 years, inclusive, at the time of randomization for Study MLN0002-2003.

  8. A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    ... Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  9. Amanda M. Johnson, M.D. - Doctors and Medical Staff - Mayo Clinic

    SubSpec FellowGI - Inflammatory Bowel Disease, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine.

  10. STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease - Mayo Clinic

    The goal of this clinical trial is to learn about the safety, pharmacokinetics and pharmacodynamics of AGMB-129 in patients with Crohn's disease.